NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Black ER, Falzon L, Aronson N. Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Dec. (Technical Briefs, No. 13.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer

Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer [Internet].

Show details

Appendix CPublications That Did Not Provide Specific Results for Stage II Colon Cancer

1.
Ägesen TH, Sveen A, Merok MA, et al. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut. 2012 Jan 2 [PubMed: 22213796]
2.
Antonacopoulou AG, Grivas PD, Skarlas L, et al. POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? Anticancer Research. 2008 Mar–Apr;28(2B):1221–7. [PubMed: 18505059]
3.
Barrier A, Boelle P-Y, Lemoine A, et al. Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients. Diseases of the Colon & Rectum. 2005 Dec;48(12):2238–48. [PubMed: 16228831]
4.
Barrier A, Lemoine A, Boelle P-Y, et al. Colon cancer prognosis prediction by gene expression profiling. Oncogene. 2005 Sep 8;24(40):6155–64. [PubMed: 16091735]
5.
Camus M, Tosolini M, Mlecnik B, et al. Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Research. 2009 Mar 15;69(6):2685–93. [PubMed: 19258510]
6.
Coppola D, Nebozhyn M, Khalil F, et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. American Journal of Pathology. 2011 Jul;179(1):37–45. [PMC free article: PMC3123872] [PubMed: 21703392]
7.
Deves C, Renck D, Garicochea B, et al. Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer. Virchows Archiv. 2011 Apr;458(4):421–30. [PubMed: 21318373]
8.
Fritzmann J, Morkel M, Besser D, et al. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology. 2009 Jul;137(1):165–75. [PubMed: 19328798]
9.
Gröene J, Mansmann U, Meister R, et al. Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. International Journal of Cancer. 2006 Oct 15;119(8):1829–36. [Erratum appears in Int J Cancer. 2007 Jul 15;121(2):466] [PubMed: 16721809]
10.
Jorissen RN, Gibbs P, Christie M, et al. Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clin Cancer Res. 2009 Dec 15;15(24):7642–51. [PMC free article: PMC2920750] [PubMed: 19996206]
11.
Kammula US, Kuntz EJ, Francone TD, et al. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Letters. 2007 Apr 18;248(2):219–28. [PubMed: 16945480]
12.
Kornmann M, Schwabe W, Sander S, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clinical Cancer Research. 2003 Sep 15;9(11):4116–24. [PubMed: 14519634]
13.
Loboda A, Nebozhyn MV, Watters JW, et al. EMT is the dominant program in human colon cancer. BMC Medical Genomics. 2011;4:9. [Electronic Resource] [PMC free article: PMC3032646] [PubMed: 21251323]
14.
Lassmann S, Hennig M, Rosenberg R, et al. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up. International Journal of Colorectal Disease. 2006 Apr;21(3):238–47. [PubMed: 16132996]
15.
Lenehan PF, Boardman LA, Riegert-Johnson D, et al. Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma. Cancer. 2012 May 17 [PMC free article: PMC3532613] [PubMed: 22605513]
16.
Lin Y-H, Friederichs J, Black MA, et al. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clinical Cancer Research. 2007 Jan 15;13(2 Pt 1):498–507. [PubMed: 17255271]
17.
Merlos-Suarez A, Barriga FM, Jung P, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011 May 6;8(5):511–24. [PubMed: 21419747]
18.
Nitsche U, Maak M, Schuster T, et al. ColoPrint® – ein vielversprechender Gentest zur Risikoabschätzung bei Patienten mit Kolonkarzinom. Journal Onkologie. 2012:454–6. (english language abstract)
19.
Popovici V, Budinska E, Tejpar S, et al. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J Clin Oncol. 2012 Apr 20;30(12):1288–95. [PubMed: 22393095]
20.
Pogue-Geile KL, Yothers GA, Gavin P, et al. Use of a prognostic (prog) gene index and nodal status to identify a subset of stage II and III colon cancer patients (pts) who may not need oxaliplatin (ox)-containing adjuvant chemotherapy. Journal of Clinical Oncology Conference. 2010;28(15 SUPPL 1)
21.
Staub E, Groene J, Heinze M, et al. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. Journal of Molecular Medicine. 2009 Jun;87(6):633–44. [PMC free article: PMC2688022] [PubMed: 19399471]
22.
Vendrell E, Ribas M, Valls J, et al. Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International Journal of Oncology. 2007 May;30(5):1099–107. [PubMed: 17390011]
23.
Yamasaki M, Takemasa I, Komori T, et al. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. International Journal of Oncology. 2007 Jan;30(1):129–38. [PubMed: 17143521]
Bookshelf ID: NBK115807

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (436K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...